摘要
目的通过观察芪参还五胶囊治疗气虚血瘀型血管性痴呆的临床疗效及安全性,旨在为血管性痴呆寻求一种安全有效的治疗方法。方法将符合纳入病例标准的60例血管性痴呆患者随机分成芪参还五胶囊治疗组和尼莫地平片对照组。2组患者分别在治疗前和治疗后8周进行精神状态检查量表(MMSE)和日常生活能力量表(ADL)进行评分,并进行统计学分析。结果芪参还五胶囊可以显著改善气虚血瘀型VD患者MMSE、ADL评分,且无不良反应。结论芪参还五胶囊可改善血管性痴呆患者的症状,是治疗气虚血瘀型血管性痴呆安全有效的药物。
Objective By observing the clinical curative effect and security of Qishenhuanwu capsules in treatment of Vascular Dementia of QiXuXueYu type,to seek a safe and effective treatment for vascular dementia. Methods Sixty patients with vascular dementia were met inclusion criteria and randomly divided into two groups： treatment group treated with Qishenhuanwu capsules and control group treated with Nimodiping tablets.Mini- mental state examination（MMSE） smart scale and activity of daily（ADL）score of two groups were assessed and compared before treatment and eight weeks after treatment. Results The score of MMSE and ADL were improved in Qishenhuanwu capsules group. Conclusion Qishenhuanwu capsules could improve clinical symptoms in patients with vascular dementia. Qishenhuanwu capsules was effective and safe for the treatment of vascular dementia of QiXuXueYu type.
出处
《现代中药研究与实践》
CAS
2013年第6期85-87,共3页
Research and Practice on Chinese Medicines
